Malek, Anastasia <br/><br/>
HMGA2 gene is a promising target for ovarian cancer silencing therapy.  [electronic resource] 

 -  International journal of cancer  Jul 2008 
 - 348-356 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.23491  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis<br/>Blotting, Western<br/>Carcinoma--genetics<br/>Cell Cycle<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Cell Survival<br/>Cystadenocarcinoma, Serous--genetics<br/>Female<br/>Flow Cytometry<br/>Gene Expression Regulation, Neoplastic<br/>Gene Silencing<br/>Genetic Therapy--methods<br/>HMGA2 Protein--genetics<br/>Humans<br/>In Situ Hybridization<br/>Mice<br/>Mice, Nude<br/>Ovarian Neoplasms--genetics<br/>RNA, Small Interfering--metabolism<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Transfection<br/>Transplantation, Heterologous<br/>Up-Regulation